St Germain D J CO Inc Novo Nordisk A S Call Options Transaction History
St Germain D J CO Inc
- $2.4 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,702Shares Held
293MCall Options Held
13.8MPut Options Held
19.7M-
Bank Of America Corp Charlotte, NC14.7MShares$723 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$702 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$618 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$571 Million0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11MShares$540 Million0.31% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $111B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...